Forefront Analytics LLC decreased its position in shares of Mereo BioPharma Group plc (NASDAQ:MREO – Free Report) by 20.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 65,649 shares of the company’s stock after selling 17,100 shares during the […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the target of a significant drop in short interest during the month of September. As of September 15th, there was short interest totalling 3,560,000 shares, a drop of 26.6% from the August 31st total of 4,850,000 shares. Based on an average trading volume of 916,500 […]
Mereo BioPharma Group (NASDAQ:MREO – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.02) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.02), MarketWatch Earnings reports. Mereo BioPharma Group Trading Down 1.4 % MREO stock opened at $1.41 on Friday. Mereo BioPharma Group has a fifty-two […]
Needham & Company LLC reissued their buy rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $5.00 target price on the stock. Mereo BioPharma Group Price Performance MREO opened at $1.60 on Wednesday. Mereo BioPharma Group has a […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 6,200,000 shares, a decline of 19.5% from the July 15th total of 7,700,000 shares. Based on an average daily volume of 1,830,000 […]